Thyroid Cancer J. Koerting eines Arzneimittels

eines Arzneimittels

The justification for yearbooks is greater than ever as we approach the third millennium

and 1 adulterated by British authority

Die Entwicklung hin zu einem Wettbewerbsumfeld

Thyroid Cancer J. Koerting eines ArzneimittelsOne of the main reasons for publishing this second edition of T roid Cancer is the fact that the first edition has sold out. Furth more, during the 4 years following the publication of the first edition in 2001, some progress, mainly in the basic sciences (molecular biology), has been made. The most prominent change in the clinical sciences has been the new classification of thyroid cancer, especially with relation to T1T3 tumors. Now, tumors with a